Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)-Reference-Cited by-同舟云学术

Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)

Published:2016-02-05 Issue:2 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

da Silva Edina MK¹,Strufaldi Maria Wany Louzada²,Andriolo Regis B³,Silva Laercio A⁴

Affiliation:

1. Universidade Federal de São Paulo; Emergency Medicine and Evidence Based Medicine; Rua Borges Lagoa 564 cj 64 Vl. Clementino São Paulo São Paulo Brazil 04038-000

2. Universidade Federal de São Paulo; São Paulo São Paulo Brazil

3. Universidade do Estado do Pará; Department of Public Health; Travessa Perebebuí, 2623 Belém Pará Brazil 66087-670

4. Universidade Federal de São Paulo; Department of Urology; Rua Doutor Nicolau de Sousa Queiros, 629. Ap.130B São Paulo São Paulo Brazil 04105002

Publisher

Wiley

Subject

Pharmacology (medical)

Reference37 articles.

1. Long-term weekly dosing of idursulfase in the treatment of mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract];Beck;Journal of Inherited Metabolic Disease,2007

2. Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome;Muenzer;Genetics in Medicine,2011

3. Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) [abstract];Muenzer;Journal of Inherited Metabolic Disease,2006

4. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome);Muenzer;Genetics in Medicine,2006

5. Clinical study of enzyme replacement therapy with idursulfase;Gutiérrez-Solana;Revista de Neurologia,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis II;Orphanet Journal of Rare Diseases;2024-03-10

2. An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II;Molecular Therapy;2024-03

3. Idursulfase Beta (Hunterase) Therapeutic Experience in a Patient with Mucopolysaccharidosis Type II;Current Pediatrics;2023-08-25

4. Mucopolysaccharidosis: An overview and new treatment modalities;International Journal of Clinical Biochemistry and Research;2023-07-15

5. Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II;Pediatric pharmacology;2022-07-12